Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,090 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome.
Gilchrist CA, Houpt E, Trapaidze N, Fei Z, Crasta O, Asgharpour A, Evans C, Martino-Catt S, Baba DJ, Stroup S, Hamano S, Ehrenkaufer G, Okada M, Singh U, Nozaki T, Mann BJ, Petri WA Jr. Gilchrist CA, et al. Among authors: okada m. Mol Biochem Parasitol. 2006 Jun;147(2):163-76. doi: 10.1016/j.molbiopara.2006.02.007. Epub 2006 Mar 7. Mol Biochem Parasitol. 2006. PMID: 16569449
Efficacy of anifrolumab on systemic lupus erythematosus patients with serological manifestations: A post hoc analysis of the Japan subgroup of the TULIP-2 Trial.
Tanaka Y, Atsumi T, Okada M, Miyamura T, Ishii T, Nishiyama S, Matsumura R, Hayashi N, Matsumoto T, Yabe-Wada T, Yamaguchi Y, Abreu G, Lindholm C, Takeuchi T. Tanaka Y, et al. Among authors: okada m. Mod Rheumatol. 2025 Jan 17:roae111. doi: 10.1093/mr/roae111. Online ahead of print. Mod Rheumatol. 2025. PMID: 39821415
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: post hoc analysis of the Japanese subpopulation of the TULIP-2 study.
Tanaka Y, Atsumi T, Okada M, Miyamura T, Ishii T, Nishiyama S, Matsumura R, Morishima Y, Yamaguchi Y, Abreu G, Lindholm C, Morand EF, Takeuchi T. Tanaka Y, et al. Among authors: okada m. Mod Rheumatol. 2025 Jan 13:roae105. doi: 10.1093/mr/roae105. Online ahead of print. Mod Rheumatol. 2025. PMID: 39801286
Efficacy and safety of enfortumab vedotin in older patients with metastatic urothelial carcinoma: A multicenter retrospective study.
Shindo T, Hashimoto K, Kenuka T, Miyamoto S, Hiyama Y, Fukuta F, Kunishima Y, Okada M, Matsukawa M, Kato R, Senda M, Wanifuchi A, Sato S, Kobayashi K, Tanaka T, Masumori N; Sapporo Medical University Urologic Oncology Consortium. Shindo T, et al. Among authors: okada m. J Geriatr Oncol. 2025 Jan 9;16(2):102183. doi: 10.1016/j.jgo.2024.102183. Online ahead of print. J Geriatr Oncol. 2025. PMID: 39793527
6,090 results